|
Volumn 28, Issue 6, 2008, Pages
|
The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
ANGIOID STREAK;
CASE REPORT;
DRUG ANTAGONISM;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
INJECTION;
MIDDLE AGED;
NOTE;
OPTICAL COHERENCE TOMOGRAPHY;
PSEUDOXANTHOMA ELASTICUM;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT OUTCOME;
VISUAL ACUITY;
VITREOUS BODY;
ANGIOGENESIS INHIBITORS;
ANGIOID STREAKS;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INJECTIONS;
MIDDLE AGED;
PSEUDOXANTHOMA ELASTICUM;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
EID: 47749141521
PISSN: 0275004X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (7)
|
References (0)
|